Rojas García, William ;
Flórez Romero, Andrés ;
Pinzón Rincón, DianaStatland J, Phillips L, Triverdi J. Muscle channelopathies. Neurol Clin. 2014;32:801–15. 2. Fontaine B. Periodic paralysis. Adv Genet. 2008;63:3–23. 3. Statland J, Barohn R. Muscle channelopathies: The nondystrophic myotonias and periodic paralyses. Continuum (Minneap Minn). 2014;19:1598–614. 4. Imbrici P, Liantonio A, Camerino G, de Bellis M, Camerino C, Mele A, et al. Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery. Front Pharmacol. 2016;7:121. 5. Ke T, Gomez CR, Mateus HE, Castano JA, Wang QK. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family. J Hum Genet. 2009;54:60–4. 6. Zheng J, Liang Z, Hou Y, Liu F, Hu Y, Lin P, et al. A novel Kir2.6 mutation associated with hypokalemic periodic paralysis. Clin Nuerophysiol. 2016;127:2503–8. 7. Burge JA, Hanna MG. Novel insights into the pathomechanisms of eskeletal muscle channelopathies. Curr Neurol Neur....
,
2022
